Oklo (OKLO) has spent most of 2026 working on nuclear reactor deployment, signing landmark deals, and advancing fuel recycling technology. But Wall Street's attention is shifting to a different kind of energy building around OKLO stock: short interest. Bears have piled in heavily, yet a fast-growing list of catalysts suggests that the pressure could flip fast.
According to a report, through the end of April, Oklo carried the highest short interest among utility stocks with market capitalizations above $2 billion, with 16.45% of its shares outstanding sold short. Accordingly, a potential short squeeze — not earnings — could be the next big catalyst for investors.
For context, OKLO stock is up 9% so far in 2026, compared to the S&P 500 Index's ($SPX) gain of 7.5%.
Oklo Has a Robust Pipeline
One key development for Oklo in recent months was its prepayment agreement with Meta Platforms (META), structured to support plans for a 1.2 gigawatt power campus in Pike County, Ohio. The initial phase of the agreement targets 150 megawatts (MW) of capacity by around 2030, and Meta's prepayment is expected to fund near-term fuel procurement.
Oklo CEO Jacob DeWitte called Meta an anchor customer that will help pull in others. "Finding the first customer is the biggest hurdle to get into," DeWitte said on the company's latest earnings call. "It creates a pretty powerful dynamic."
Beyond Meta Platforms, Oklo is in active discussions with industrial customers and the U.S. military, particularly for applications in Alaska.
In April 2026, Oklo also collaborated with Nvidia (NVDA) and Los Alamos National Laboratory to advance AI-enabled nuclear fuel research. The agreement aims to integrate advanced nuclear power, digital twins, and materials science to support nuclear-powered AI factories. The work includes physics-based AI models for plutonium-bearing fuel validation and grid stabilization studies, which tie directly into the U.S. government's Genesis Mission. The announcement puts Oklo at the intersection of nuclear energy and AI infrastructure — a pairing that the market has not fully priced in.
While Oklo is pre-revenue, the company recently broke ground on its first Aurora powerhouse at Idaho National Laboratory and received its first Nuclear Regulatory Commission (NRC) materials license through its Atomic Alchemy subsidiary. Oklo is also targeting criticality at its Groves radioisotope test reactor by July 4.
"We are demonstrating that new nuclear can deploy at pace," DeWitte said on the fourth-quarter earnings call.
In March 2026, Oklo expanded its partnership with Swedish firm Blykalla as well, with planned investments ranging from $100 million to $200 million and commitments of 30 to 40 engineers.
Oklo ended 2025 with $1.4 billion in cash. It also added $1.18 billion in January through an at-the-market equity program. Oklo’s free cash outflow is expected to total $1.6 billion through 2030, suggesting it has sufficient liquidity to fund its near-term cash burn rate.
What Do Analysts Think of OKLO Stock?
Out of the 21 analysts covering OKLO stock, 11 recommend a “Strong Buy,” three recommend a “Moderate Buy,” six recommend a “Hold” rating, and one analyst recommends a “Strong Sell” rating. The average price target is $88.66, implying 12% potential upside from current levels.
The bear case against Oklo has centered on the company being pre-revenue, expensive, and dependent on regulatory approvals. But with a string of positive catalysts, a well-capitalized balance sheet, and policy tailwinds accelerating in licensing and fuel supply, the short-squeeze setup favors the bulls.
Short sellers betting against Oklo now have to contend with Meta, Nvidia, a U.S. Department of Energy (DOE) reactor program, and an NRC license already in hand. That is a lot of good news for a stock carrying the heaviest short load in its sector.
On the date of publication, Aditya Raghunath did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
